Novartis now says that it paid Trump's attorney $1.2M — and then throws ex-CEO Joe Jimenez under the bus
BioRegnum — The view from John Carroll
With Novartis stuck squarely in the middle of a media frenzy centered on payments it made to a shell company controlled by Michael Cohen, the personal attorney for President Donald Trump, the pharma giant offered a few more details Wednesday about their relationship. It starts with an admission that Novartis actually paid Cohen more than a million dollars, and it was followed by an extraordinary private admission that then CEO Joe Jimenez was sold on the notion that Cohen could private access to the administration.
This article is for premium subscribers only
Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.
